Funding Details
- Awarder
- Inbox
- Date Award
- July 16, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases. Cardurion was founded by physician-scientists with world-class expertise in cardiovascular signaling pathways, and a shared passion to find and develop a pipeline of novel treatment options to improve the lives of patients.
- Market
- Cardiovascular diseases
- Location
-
Burlington,
MA,
USA
- Coinvestors
- Ascenta Capital, Bain Capital Life Sciences, Blue Owl, Delos Capital, Digitalis Ventures, Farallon Capital Management, Fidelity Management & Research Company, GV, Invus Capital, Millennium Management, NEA Ventures
Links